EUVIMEDEUVIMED entdecken
Crossref

Discovery of antiepileptic Q-Markers for Bombyx batryticatus: Integrating serum pharmacochemistry, network pharmacology and temporal-efficacy validation

Yunhua Feng, Zhenyang Li, Huijie Sun, Yu Hu, Jianguo Sun, Ying Peng, Kaicheng Xie, Jinyi Sui, Yang Li, Jiandong Zou, Meijuan Xu

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yunhua Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, 210029, Jiangsu,…. Hauptthemen laut MEDLINE: Anticonvulsants, Bombyx, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Bombyx batryticatus (BB) is a well-known animal-derived traditional Chinese medicine (TCM) commonly used for the treatment of epilepsy, convulsions, headaches, and other disorders. However, quality evaluation and control of BB remains incomplete, necessitating robust quality control paradigms. AIM OF THE STUDY: To identify the Quality markers (Q-markers) of BB for the treatment of epilepsy by integrating serum pharmacochemistry, network pharmacology, HPLC-UV quantification, and temporal-efficacy validation, all in accordance with the core principles of Q-markers. MATERIALS AND METHODS: Initially, Q-markers candidates were screened through serum pharmacochemistry-based tracing to achieve "traceability". Additionally, network pharmacology predictions and relevant literature were consulted to confirm potential bioactivity. Next, fingerprint and their contents in BB were determined by HPLC-UV, which provided the dosage basis for the efficacy validation experiment and ensured of "measurability". Finally, their antiepileptic effects were investigated through a temporal pharmacodynamic study using acute pentylenetetrazole (PTZ)-induced mouse epilepsy model to ensure "pharmacological effectiveness". RESULTS: HPLC-Q-TOF/MS analysis identified 65 compounds in the BB extract, of which 31 were found in mouse serum, including 9 amino acids, 4 nucleosides, 8 peptides, 5 fatty acids, 3 organic acids and 2 other components. Only 8 cyclic peptides were screened for network pharmacology analysis, and 4 potential bioactive components were selected for HPLC-UV quantification. The average contents of the final selected candidates across 15 batches of BB were as follows: beauvericin at 192.3 μg/g, bassianolide at 325.6 μg/g, and ammonium oxalate at 66515 μg/g. The PTZ model experiment showed that BB powder suspension (0.86 g/kg, i.g.) significantly prolonged seizure latency from 1 to 8 h (P < 0.05) with fluctuating efficacy (the maximum effect Emax1 at 3 h and Emax2 at 8 h). Ammonium oxalate (50 mg/kg, i.g.) demonstrated rapid-onset protection (Emax at 1-2 h), significantly increasing seizure latency at 1-4 h (P < 0.01) and achieving 90 % survival rate at 2 h (vs. 30 % model, P < 0.05), suggesting its role as an active ingredient in the early stage of BB's anticonvulsant effects. Beauvericin and bassianolide showed delayed efficacy (both Emax at 6 h), significantly extending seizure latency at 4-8 h and 2-8 h (P < 0.05), respectively, indicating their potential as active ingredients in the later stage. CONCLUSION: Beauvericin, bassianolide and ammonium oxalate could be used as the Q-markers of BB, and the strategy applied in this study could effectively aid in identifying Q-markers for other TCMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsBombyxEpilepsyAnimalsMiceNetwork PharmacologyMalePentylenetetrazoleDisease Models, AnimalChromatography, High Pressure LiquidMedicine, Chinese TraditionalSeizures

Stichwörter der Autor:innen

Ammonium oxalateBassianolideBeauvericinBombyx batryticatusQuality marker

Substanzen

AnticonvulsantsPentylenetetrazole

Autor:innen und Institutionen

  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, 210029, Jiangsu, China.
  • China Pharmaceutical University, Nanjing, 210009, Jiangsu, China.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, 210029, Jiangsu, China. Electronic address: jdzou2000@163.com.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, 210029, Jiangsu, China. Electronic address: windcolour11@126.com.

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Feng, Y., Li, Z., Sun, H., Hu, Y., Sun, J., Peng, Y., Xie, K., Sui, J., Li, Y., Zou, J., & Xu, M. (2025). Discovery of antiepileptic Q-Markers for Bombyx batryticatus: Integrating serum pharmacochemistry, network pharmacology and temporal-efficacy validation. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119992

Vancouver

Feng Y, Li Z, Sun H, Hu Y, Sun J, Peng Y, et al. Discovery of antiepileptic Q-Markers for Bombyx batryticatus: Integrating serum pharmacochemistry, network pharmacology and temporal-efficacy validation. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119992

BibTeX
@article{Feng2025,
  author = {Feng, Yunhua and Li, Zhenyang and Sun, Huijie and Hu, Yu and Sun, Jianguo and Peng, Ying and Xie, Kaicheng and Sui, Jinyi and Li, Yang and Zou, Jiandong and Xu, Meijuan},
  title = {Discovery of antiepileptic Q-Markers for Bombyx batryticatus: Integrating serum pharmacochemistry, network pharmacology and temporal-efficacy validation},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119992}
}
Kostenlos starten →